Imugene moves forward with cancer vax trial news release
MELBOURNE: Paul Hopper’s $2.7 billion cancer biotech Imugene will move forward with trials for a
MELBOURNE: Paul Hopper’s $2.7 billion cancer biotech Imugene will move forward with trials for a
FEATURED
Nine-story homeless tower rejected by council in shock vote
Multigenerational affordable housing planned for regeneration site
Baby boomers shock choice on who gets growing inheritance
Nimbys fight retirement village redevelopment plan for beach precinct
New residential care facility now being proposed for suburban location
Six-storey social housing development now on drawing board
INNOVATION
